Literature DB >> 19793820

Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherin.

Mariana G Bego1, Mathieu Dubé, Johanne Mercier, Eric A Cohen.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpu enhances virus particle release by counteracting a host factor that retains virions at the surfaces of infected cells. It was recently demonstrated that cellular protein BST-2/CD317/Tetherin restricts HIV-1 release in a Vpu-dependent manner. Calcium-modulating cyclophilin ligand (CAML) was also proposed to be involved in this process. We investigated whether CAML is involved in cell surface expression of Tetherin. Here, we show that CAML overexpression in permissive Cos-7 cells or CAML depletion in restrictive HeLa cells has no effect on HIV-1 release or on Tetherin surface expression, indicating that CAML is not required for Tetherin-mediated restriction of HIV-1 release.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793820      PMCID: PMC2786830          DOI: 10.1128/JVI.01786-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.

Authors:  Andrés Finzi; Alexandre Brunet; Yong Xiao; Jacques Thibodeau; Eric A Cohen
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

3.  NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.

Authors:  R Q Cron; S R Bartz; A Clausell; S J Bort; S J Klebanoff; D B Lewis
Journal:  Clin Immunol       Date:  2000-03       Impact factor: 3.969

4.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

5.  CAML is required for efficient EGF receptor recycling.

Authors:  David D Tran; Helen R Russell; Shari L Sutor; Jan van Deursen; Richard J Bram
Journal:  Dev Cell       Date:  2003-08       Impact factor: 12.270

6.  Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABA(A) receptors.

Authors:  Xu Yuan; Jun Yao; David Norris; David D Tran; Richard J Bram; Gong Chen; Bernhard Luscher
Journal:  Mol Cell Neurosci       Date:  2008-03-13       Impact factor: 4.314

7.  CAML loss causes anaphase failure and chromosome missegregation.

Authors:  Yu Liu; Liviu Malureanu; Karthik B Jeganathan; David Dinh Tran; Lonn D Lindquist; Jan M van Deursen; Richard J Bram
Journal:  Cell Cycle       Date:  2009-03-26       Impact factor: 4.534

8.  Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.

Authors:  Vasundhara Varthakavi; Ellen Heimann-Nichols; Rita M Smith; Yuehui Sun; Richard J Bram; Showkat Ali; Jeremy Rose; Lingmei Ding; Paul Spearman
Journal:  Nat Med       Date:  2008-05-25       Impact factor: 53.440

9.  Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network.

Authors:  Mathieu Dubé; Bibhuti Bhusan Roy; Pierre Guiot-Guillain; Johanne Mercier; Julie Binette; Grace Leung; Eric A Cohen
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

10.  Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Authors:  Richard S Mitchell; Chris Katsura; Mark A Skasko; Katie Fitzpatrick; David Lau; Autumn Ruiz; Edward B Stephens; Florence Margottin-Goguet; Richard Benarous; John C Guatelli
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  6 in total

1.  Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling.

Authors:  Mariana G Bego; Johanne Mercier; Eric A Cohen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains.

Authors:  Mariana G Bego; Lijun Cong; Katharina Mack; Frank Kirchhoff; Éric A Cohen
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

3.  Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

Authors:  Mariana G Bego; Édouard A Côté; Éric A Cohen
Journal:  J Vis Exp       Date:  2015-09-01       Impact factor: 1.355

4.  CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.

Authors:  Mohammed S Ali; Jason Hammonds; Lingmei Ding; Paul Spearman
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

5.  Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.

Authors:  Mariana G Bego; Édouard Côté; Nick Aschman; Johanne Mercier; Winfried Weissenhorn; Éric A Cohen
Journal:  PLoS Pathog       Date:  2015-07-14       Impact factor: 6.823

Review 6.  Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.

Authors:  Siobhan Gargan; Nigel J Stevenson
Journal:  Viruses       Date:  2021-10-27       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.